These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9037635)

  • 1. Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process.
    Gross-Weege W; Weiss M; Schneider M; Wenning M; Harms B; Dumon K; Ohmann C; Röher HD
    Intensive Care Med; 1997 Jan; 23(1):16-22. PubMed ID: 9037635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.
    Weiss M; Gross-Weege W; Schneider M; Neidhardt H; Liebert S; Mirow N; Wernet P
    J Crit Care; 1995 Mar; 10(1):21-6. PubMed ID: 7538851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filgrastim (RHG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis.
    Weiss M; Gross-Weege W; Harms B; Schneider EM
    Cytokine; 1996 Mar; 8(3):260-5. PubMed ID: 8833041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients.
    Gruson D; Hilbert G; Vargas F; Valentino R; Chene G; Boiron JM; Reiffers J; Gbikpi-Benissan G; Cardinaud JP
    Crit Care Med; 2000 Sep; 28(9):3155-60. PubMed ID: 11008974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study.
    Pettilä V; Takkunen O; Varpula T; Markkola A; Porkka K; Valtonen V
    Crit Care Med; 2000 Nov; 28(11):3620-5. PubMed ID: 11098963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filgrastim in patients with pneumonia and severe sepsis or septic shock.
    Wunderink R; Leeper K; Schein R; Nelson S; DeBoisblanc B; Fotheringham N; Logan E
    Chest; 2001 Feb; 119(2):523-9. PubMed ID: 11171733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia.
    deBoisblanc BP; Mason CM; Andresen J; Logan E; Bear MB; Johnson S; Shellito J; Summer WR; Nelson S
    Respir Med; 1997 Aug; 91(7):387-94. PubMed ID: 9327037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group.
    Heard SO; Fink MP; Gamelli RL; Solomkin JS; Joshi M; Trask AL; Fabian TC; Hudson LD; Gerold KB; Logan ED
    Crit Care Med; 1998 Apr; 26(4):748-54. PubMed ID: 9559614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.
    Schneider C; von Aulock S; Zedler S; Schinkel C; Hartung T; Faist E
    Ann Surg; 2004 Jan; 239(1):75-81. PubMed ID: 14685103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma.
    Fyles AW; Manchul L; Levin W; Robertson JM; Sturgeon J; Tsuji D
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):843-7. PubMed ID: 9652847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
    Shitara T; Yugami S; Ijima H; Sotomatu M; Kuroume T
    Am J Hematol; 1994 Jan; 45(1):58-62. PubMed ID: 7504401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor (G-CSF) stiffens leukocytes but attenuates inflammatory response without lung injury in septic patients.
    Tanaka H; Nishino M; Nakamori Y; Ogura H; Ishikawa K; Shimazu T; Sugimoto H
    J Trauma; 2001 Dec; 51(6):1110-6. PubMed ID: 11740262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma.
    Raina V; Sharma A; Kumar R; Bhargava M
    Cancer; 1996 Mar; 77(6):1073-8. PubMed ID: 8635126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy plus recombinant human granulocyte-colony stimulating factor support for distant metastatic nasopharyngeal carcinoma. A preliminary report.
    Wang CH; Wang HM; Chen JS; Chang WJ; Lai GM
    Oncology; 1997; 54(1):34-7. PubMed ID: 8978590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.